Norethindrone

CAT: 0804-HY-B0554-01Size: 250 mgDry Ice: NoHazardous: No
CAT#:0804-HY-B0554-01Size:250 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.
CAS Number
[68-22-4]
Product Name Alternative
Norethisterone
UNSPSC
12352211
Hazard Statement
H302, H351, H360, H410
Target
Bacterial; Progesterone Receptor
Type
Reference compound
Related Pathways
Anti-infection; Vitamin D Related/Nuclear Receptor
Applications
Neuroscience-Neuromodulation
Field of Research
Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/norethindrone.html
Purity
99.37
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 2.7 mg/mL (ultrasonic)
Smiles
C[C@@]1([C@]2(O)C#C)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@@]3([H])CC4)([H])CC1
Molecular Formula
C20H26O2
Molecular Weight
298.42
Precautions
H302, H351, H360, H410
References & Citations
[1]Muneyyirci-Delale O, et al. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Womens Med. 1998 Jan-Feb;43 (1) :24-7.|[2]Kaser DJ, et al. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol. 2012 Apr;25 (2) :105-8.|[3]Maier WE, et al. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul Toxicol Pharmacol. 2001 Aug;34 (1) :53-61.|[4]Cheng DC, et al. Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes. Atherosclerosis. 1983 Jan;46 (1) :41-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName

Alternative Products

CatalogName
TRC-N676000-1GNorethindrone
018493Norethindrone Acetate

Popular Products